Design Therapeutics, Inc.

The momentum for this stock is not very good. Design Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Design Therapeutics, Inc..

News

Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference

Globe Newswire CARLSBAD, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today...\n more…

Design Therapeutics (NASDAQ:DSGN) Stock Price Up 4.4%

Zolmax Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) was up 4.4% on Monday . The stock traded as high as $4.97 and last traded at $4.88. Approximately 162,029 shares were traded during trading...\n more…

Wall Street Analysts Think Design Therapeutics (DSGN) Could Surge 39.72%: Read This Before Placing a Bet

Zacks Investment Research Shares of Design Therapeutics, Inc. (DSGN) have gained 23.7% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if...\n more…

Price T Rowe Associates Inc. MD Invests $45,000 in Design Therapeutics, Inc. (NASDAQ:DSGN)

Ticker Report Price T Rowe Associates Inc. MD acquired a new stake in Design Therapeutics, Inc. (NASDAQ:DSGN - Free Report) in the 1st quarter, Holdings Channel reports. The firm acquired 11,147 shares of the...\n more…

Reviewing Design Therapeutics (NASDAQ:DSGN) and Annexon (NASDAQ:ANNX)

Ticker Report Annexon (NASDAQ:ANNX - Get Free Report) and Design Therapeutics (NASDAQ:DSGN - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...\n more…

Head-To-Head Survey: Design Therapeutics (NASDAQ:DSGN) & Annexon (NASDAQ:ANNX)

Zolmax Annexon (NASDAQ:ANNX - Get Free Report) and Design Therapeutics (NASDAQ:DSGN - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...\n more…